Rosiglitazone modulates multiple signalling pathways in pancreatic beta cells and protects beta cells from the detrimental effects of free fatty acids

C. Landy, T. Ali, R. Crawford, Claire Marriott, A.M. Woollhead, Moira Harrison, Wendy Macfarlane

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)467
JournalDiabetes
Volume57
Issue numberSupplement 1A
Publication statusPublished - 2008

Cite this